Top Markets
#1 Akedo Akedo +57.68%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.31%
#4 Cross Cross +43.97%
#5 OVERTAKE OVERTAKE +34.90%
#6 Black Phoenix Black Phoenix +34.01%
#7 Velvet Velvet +27.53%
#8 Cap Cap +15.60%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.31%
#10 Palladium Network Palladium Network +12.56%
Coin of the day
Akedo Akedo
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
Rang în acțiuni #39100
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
Preț acțiune
$0.02243487
Ultima sincronizare: 2025-06-04
Capitalizare de piață
$650.09K
Schimbare (1 zi)
0.39%
Schimbare (1 an)
0.00%
Țară
SE
Tranzacționează Lipidor AB (publ) (LIPI)

Categorie

Healthcare
Raport P/B pentru Lipidor AB (publ) (LIPI)
Raport P/B la data de August 2026 TTM: 12.04
Conform celor mai recente rapoarte financiare și prețului acțiunilor Lipidor AB (publ), raportul P/B actual (TTM) este 12.04. La sfârșitul anului 2023, compania avea un P/B de -1.56.
Istoricul raportului P/B pentru Lipidor AB (publ) din 2016 până în 2026
Raport P/B la sfârșitul fiecărui an
An Raport P/B Schimbă
2026 (TTM) 12.04 0.94%
2024 11.93 -862.92%
2023 -1.56 -115.74%
2022 9.94 83.15%
2021 5.43 4.17%
2020 5.21 -57.99%
2019 12.40 47.15%
2018 8.43 -75.94%
2017 35.02 -76.02%
2016 146.04 0.00%
Raport P/B pentru companii similare sau competitoare
Companie Raport P/B Diferență raport P/B Țara
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 32.9295 173.44%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7.3617 -38.87%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 -66.8597 -655.19%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 8.4776 -29.60%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 7.0166 -41.74%
US